MyAverix Finance
BE · Other
LIGAND PHARMA (LGDN)
Other
LIGAND PHARMA (LGDN) is listed on BE in the Other sector. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LGDN
P/E ratio
18.00
LIGAND PHARMA (LGDN) — FAQ
What is LGDN's P/E ratio?
The price-to-earnings (P/E) ratio for LIGAND PHARMA (LGDN) is 18.00 (data as of 2026-03-23).
Does LIGAND PHARMA pay a dividend?
Dividend yield is not available in the current snapshot for LIGAND PHARMA (LGDN). Check the MyAverix Finance app for the latest dividend data.
What sector is LIGAND PHARMA in?
LIGAND PHARMA (LGDN) is classified in the Other sector.
What exchange is LGDN listed on?
LGDN is listed on BE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.